Mitochondrial Replacement, Evolution, and the Clinic

Mitochondrial replacement therapy might bear health risks, especially for males. Mitochondrial diseases [often caused by mutations in mitochondrial DNA (mtDNA)] can manifest in a range of severe symptoms, for which there are currently no cures ( 1 ). The diseases are passed from mothers to offspring...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 2013-09, Vol.341 (6152), p.1345-1346
Main Authors: Reinhardt, Klaus, Dowling, Damian K., Morrow, Edward H.
Format: Article
Language:English
Subjects:
Deoxyribonucleic acid
Disease risks
Diseases
DNA
Evolution
Genetic mutation
Health outcomes
Mitochondria
Mitochondrial diseases
Mitochondrial DNA
Mutation
Oocytes
POLICY FORUM
Species
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3
cites cdi_FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3
container_end_page 1346
container_issue 6152
container_start_page 1345
container_title Science (American Association for the Advancement of Science)
container_volume 341
creator Reinhardt, Klaus
Dowling, Damian K.
Morrow, Edward H.
description Mitochondrial replacement therapy might bear health risks, especially for males. Mitochondrial diseases [often caused by mutations in mitochondrial DNA (mtDNA)] can manifest in a range of severe symptoms, for which there are currently no cures ( 1 ). The diseases are passed from mothers to offspring. Intense research efforts have recently focused on a germline therapeutic strategy to prevent the inheritance of disease-causing mitochondria. However, although there has been increased government interest, especially in the United Kingdom, for using this approach to treat patients, there are reasons to believe that it is premature to move this technology into the clinic at this stage.
doi_str_mv 10.1126/science.1237146
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_journals_1434084694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>42619344</jstor_id><sourcerecordid>42619344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3</originalsourceid><addsrcrecordid>eNo9kE1LAzEURYMoWKtrV8KA206bl2QyyVJK_YCKILoOmUxCU6ZJTVLBf-9Ii6u3uOfeBwehW8BzAMIX2XgbjJ0DoS0wfoYmgGVTS4LpOZpgTHktcNtcoquctxiPmaQTxF59iWYTQ5-8Hqp3ux-0sTsbyqxafcfhUHwMs0qHviobWy0HH7y5RhdOD9nenO4UfT6uPpbP9frt6WX5sK4NbdpSc4Yb6J3pGLRC2l5LaTgYIrADMM52DeZSWm1bQQCbvjOiBUKcs9B0ou3oFN0fd_cpfh1sLmobDymMLxUwyrBgXLKRWhwpk2LOyTq1T36n048CrP7UqJMadVIzNu6OjW0uMf3jjHCQlDH6C_Y2YQ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1434084694</pqid></control><display><type>article</type><title>Mitochondrial Replacement, Evolution, and the Clinic</title><source>American Association for the Advancement of Science</source><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Alma/SFX Local Collection</source><creator>Reinhardt, Klaus ; Dowling, Damian K. ; Morrow, Edward H.</creator><creatorcontrib>Reinhardt, Klaus ; Dowling, Damian K. ; Morrow, Edward H.</creatorcontrib><description>Mitochondrial replacement therapy might bear health risks, especially for males. Mitochondrial diseases [often caused by mutations in mitochondrial DNA (mtDNA)] can manifest in a range of severe symptoms, for which there are currently no cures ( 1 ). The diseases are passed from mothers to offspring. Intense research efforts have recently focused on a germline therapeutic strategy to prevent the inheritance of disease-causing mitochondria. However, although there has been increased government interest, especially in the United Kingdom, for using this approach to treat patients, there are reasons to believe that it is premature to move this technology into the clinic at this stage.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.1237146</identifier><identifier>CODEN: SCIEAS</identifier><language>eng</language><publisher>Washington: American Association for the Advancement of Science</publisher><subject>Deoxyribonucleic acid ; Disease risks ; Diseases ; DNA ; Evolution ; Genetic mutation ; Health outcomes ; Mitochondria ; Mitochondrial diseases ; Mitochondrial DNA ; Mutation ; Oocytes ; POLICY FORUM ; Species ; Therapy</subject><ispartof>Science (American Association for the Advancement of Science), 2013-09, Vol.341 (6152), p.1345-1346</ispartof><rights>Copyright © 2013 American Association for the Advancement of Science</rights><rights>Copyright © 2013, American Association for the Advancement of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3</citedby><cites>FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/42619344$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/42619344$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,2884,2885,27924,27925,58238,58471</link.rule.ids></links><search><creatorcontrib>Reinhardt, Klaus</creatorcontrib><creatorcontrib>Dowling, Damian K.</creatorcontrib><creatorcontrib>Morrow, Edward H.</creatorcontrib><title>Mitochondrial Replacement, Evolution, and the Clinic</title><title>Science (American Association for the Advancement of Science)</title><description>Mitochondrial replacement therapy might bear health risks, especially for males. Mitochondrial diseases [often caused by mutations in mitochondrial DNA (mtDNA)] can manifest in a range of severe symptoms, for which there are currently no cures ( 1 ). The diseases are passed from mothers to offspring. Intense research efforts have recently focused on a germline therapeutic strategy to prevent the inheritance of disease-causing mitochondria. However, although there has been increased government interest, especially in the United Kingdom, for using this approach to treat patients, there are reasons to believe that it is premature to move this technology into the clinic at this stage.</description><subject>Deoxyribonucleic acid</subject><subject>Disease risks</subject><subject>Diseases</subject><subject>DNA</subject><subject>Evolution</subject><subject>Genetic mutation</subject><subject>Health outcomes</subject><subject>Mitochondria</subject><subject>Mitochondrial diseases</subject><subject>Mitochondrial DNA</subject><subject>Mutation</subject><subject>Oocytes</subject><subject>POLICY FORUM</subject><subject>Species</subject><subject>Therapy</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo9kE1LAzEURYMoWKtrV8KA206bl2QyyVJK_YCKILoOmUxCU6ZJTVLBf-9Ii6u3uOfeBwehW8BzAMIX2XgbjJ0DoS0wfoYmgGVTS4LpOZpgTHktcNtcoquctxiPmaQTxF59iWYTQ5-8Hqp3ux-0sTsbyqxafcfhUHwMs0qHviobWy0HH7y5RhdOD9nenO4UfT6uPpbP9frt6WX5sK4NbdpSc4Yb6J3pGLRC2l5LaTgYIrADMM52DeZSWm1bQQCbvjOiBUKcs9B0ou3oFN0fd_cpfh1sLmobDymMLxUwyrBgXLKRWhwpk2LOyTq1T36n048CrP7UqJMadVIzNu6OjW0uMf3jjHCQlDH6C_Y2YQ4</recordid><startdate>20130920</startdate><enddate>20130920</enddate><creator>Reinhardt, Klaus</creator><creator>Dowling, Damian K.</creator><creator>Morrow, Edward H.</creator><general>American Association for the Advancement of Science</general><general>The American Association for the Advancement of Science</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QQ</scope><scope>7QR</scope><scope>7SC</scope><scope>7SE</scope><scope>7SN</scope><scope>7SP</scope><scope>7SR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7TK</scope><scope>7TM</scope><scope>7U5</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20130920</creationdate><title>Mitochondrial Replacement, Evolution, and the Clinic</title><author>Reinhardt, Klaus ; Dowling, Damian K. ; Morrow, Edward H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Deoxyribonucleic acid</topic><topic>Disease risks</topic><topic>Diseases</topic><topic>DNA</topic><topic>Evolution</topic><topic>Genetic mutation</topic><topic>Health outcomes</topic><topic>Mitochondria</topic><topic>Mitochondrial diseases</topic><topic>Mitochondrial DNA</topic><topic>Mutation</topic><topic>Oocytes</topic><topic>POLICY FORUM</topic><topic>Species</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reinhardt, Klaus</creatorcontrib><creatorcontrib>Dowling, Damian K.</creatorcontrib><creatorcontrib>Morrow, Edward H.</creatorcontrib><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Ecology Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reinhardt, Klaus</au><au>Dowling, Damian K.</au><au>Morrow, Edward H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial Replacement, Evolution, and the Clinic</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><date>2013-09-20</date><risdate>2013</risdate><volume>341</volume><issue>6152</issue><spage>1345</spage><epage>1346</epage><pages>1345-1346</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><coden>SCIEAS</coden><abstract>Mitochondrial replacement therapy might bear health risks, especially for males. Mitochondrial diseases [often caused by mutations in mitochondrial DNA (mtDNA)] can manifest in a range of severe symptoms, for which there are currently no cures ( 1 ). The diseases are passed from mothers to offspring. Intense research efforts have recently focused on a germline therapeutic strategy to prevent the inheritance of disease-causing mitochondria. However, although there has been increased government interest, especially in the United Kingdom, for using this approach to treat patients, there are reasons to believe that it is premature to move this technology into the clinic at this stage.</abstract><cop>Washington</cop><pub>American Association for the Advancement of Science</pub><doi>10.1126/science.1237146</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 2013-09, Vol.341 (6152), p.1345-1346
issn 0036-8075
1095-9203
language eng
recordid cdi_proquest_journals_1434084694
source American Association for the Advancement of Science; JSTOR Archival Journals and Primary Sources Collection; Alma/SFX Local Collection
subjects Deoxyribonucleic acid
Disease risks
Diseases
DNA
Evolution
Genetic mutation
Health outcomes
Mitochondria
Mitochondrial diseases
Mitochondrial DNA
Mutation
Oocytes
POLICY FORUM
Species
Therapy
title Mitochondrial Replacement, Evolution, and the Clinic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A05%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20Replacement,%20Evolution,%20and%20the%20Clinic&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Reinhardt,%20Klaus&rft.date=2013-09-20&rft.volume=341&rft.issue=6152&rft.spage=1345&rft.epage=1346&rft.pages=1345-1346&rft.issn=0036-8075&rft.eissn=1095-9203&rft.coden=SCIEAS&rft_id=info:doi/10.1126/science.1237146&rft_dat=%3Cjstor_proqu%3E42619344%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-64051dfcb41789eda99c61c280f11cfeb50699eae78210cdbc87122ffe15b87b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1434084694&rft_id=info:pmid/&rft_jstor_id=42619344&rfr_iscdi=true